Prescribing oral amoxicillin for orofacial infections; pharmacokinetic perspectives: a review article
Keywords:Amoxicillin, Dentistry, Infections, Pharmacokinetics, Oro-facial
Despite the continuous efforts to synthesize new antibacterial compounds, most are still at a pre-clinical stage and shortage of new antibiotics is anticipated. Therefore, it is necessary to make the best use of currently available agents. Amoxicillin is the most commonly used antibiotic for treatment of orofacial infections as well as prophylaxis of endocarditis in children and adults. Understanding the pharmacokinetics of drugs helps to shape the appropriate clinical practices and provide guidance for clinicians. Clinical guidelines for prescribing have been established and explained in several resources. However the pharmacokinetic basis for prescribing is probably an underestimated and less tackled area among clinicians. Therefore, we critically reviewed the literature is to describe pharmacokinetics of oral amoxicillin in orofacial infections to provide better understanding of the guidelines and aid evidence-based prescribing practices.
Ume H, Takai Y, Amano S, Takematsu K, Nakaya S. Jpn J Antibiot. 1977;30(5):334-337.
Dar-Odeh N, Fadel HT, Abu-Hammad S, Abdeljawad R, Abu-Hammad OA. Antibiotic Prescribing for Oro-Facial Infections in the Paediatric Outpatient: A Review. Antibiotics (Basel). 2018;7(2):38.
Caruso SR, Yamaguchi E, Portnof JE. Update on Antimicrobial Therapy in Management of Acute Odontogenic Infection in Oral and Maxillofacial Surgery. Oral Maxillofac Surg Clin North Am. 2022;34(1):169-177.
Roy J. The top five most common or long-selling drugs, An Introd. to Pharm. Sci. 2011; 231–296.
Jacobs MR. Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters. Clin Microbiol Infect. 2001;7(11):589-596.
Kumar P. Pharmacology of Specific Drug Groups: Antibiotic Therapy, Pharmacol. Ther. Dent. Seventh Ed., 2017; 457–487.
Elmanama AA, El-Aydi I, Al-Reefi M, and Ferwana N. Antibiogram of bacterial isolates from clinical specimens during 2018-2020 at Al-Aqsa hospital, Gaza, Palestine. Int. Arab. J. Antimicrob. Agents. 2022; 12 (2).
Al-Tamimi M, Albalawi H, Isied W, Musallam A, Qazzaz F, Azab M, Abu-raideh J, Himsawi N, Vaughan J. Gram-positive bacterial infections and antibiotics resistance in Jordan: current status and future perspective. J Med J 2022; 56(1):71- 44.
Chardin H, Yasukawa K, Nouacer N, Plainvert C, Aucouturier P, Ergani A, et al. Reduced susceptibility to amoxicillin of oral streptococci following amoxicillin exposure. J Med Microbiol. 2009 Aug;58(Pt 8):1092-1097.
Groppo FC, Castro FM, Pacheco AB, Motta RH, Filho TR, Ramacciato JC, Florio FM, Meechan JG. Antimicrobial resistance of Staphylococcus aureus and oral streptococci strains from high-risk endocarditis patients. Gen Dent. 2005 Nov-Dec;53(6):410-3.
Dar-Odeh N, Shehabi A, Al-Bitar Z, Al-Omari I, Badran S, Al-Omiri M. Oral Candida colonization in patients with fixed orthodontic appliances: The importance of some nutritional and salivary factors. Afr J Microbiol Res. 2011;5:2150–2154.
Dar-Odeh N; Othman B; Bahabri R; Alnazzawi A; Borzangy S; Fadel H; Alolayen AB; Abu-Hammad OA. Antibiotic Self-Medication for Oral Conditions: Characteristics and Associated Factors. Pesqui. Bras. Odontopediatria Clínica Integr. 2018; 18: 1–10.
Van Bambeke F, Barcia-Macay M, Lemaire S, Tulkens PM. Cellular pharmacodynamics and pharmacokinetics of antibiotics: current views and perspectives. Curr Opin Drug Discov Devel. 2006 Mar;9(2):218-30.
MacGregor RR, Graziani AL. Oral administration of antibiotics: a rational alternative to the parenteral route. Clin Infect Dis. 1997 Mar;24(3):457-67.
Levi ME, Eusterman VD. Oral infections and antibiotic therapy. Otolaryngol Clin North Am. 2011 Feb;44(1):57-78.
Segura-Egea JJ, Gould K, Şen BH, Jonasson P, Cotti E, Mazzoni A, Sunay H, Tjäderhane L, Dummer PMH. Antibiotics in Endodontics: a review. Int Endod J. 2017 Dec;50(12):1169-1184.
Huttner A, Bielicki J, Clements MN, Frimodt-Møller N, Muller AE, Paccaud JP, et al. Oral amoxicillin and amoxicillin-clavulanic acid: properties, indications and usage. Clin Microbiol Infect. 2020 Jul;26(7):871-879.
Klimek JJ, Nightingale C, Lehmann WB, Quintiliani R. Comparison of concentrations of amoxicillin and ampicillin in serum and middle ear fluid of children with chronic otitis media. J Infect Dis. 1977 Jun;135(6):999-1002.
Grimer RJ, Karpinski MR, Andrews JM, Wise R. Penetration of amoxycillin and clavulanic acid into bone. Chemotherapy. 1986;32(3):185-91.
Weismeier K, Adam D, Heilmann HD, Koeppe P. Penetration of amoxycillin/clavulanate into human bone. J Antimicrob Chemother. 1989 Nov;24 Suppl B:93-100.
Schüssl Y, Pelz K, Kempf J, Otten JE. Concentrations of amoxicillin and clindamycin in teeth following a single dose of oral medication. Clin Oral Investig. 2014 Jan;18(1):35-40.
Liu Y, Duan D, Xin Y, Bai L, Li T, Li C, et al. A review of the literature: antibiotic usage and its relevance to the infection in periodontal flaps. Acta Odontol Scand. 2017 May;75(4):288-293.
Bürgi H. Intérêt en pneumologie d'une nouvelle pénicilline semi-synthétique à large spectre: l'amoxicilline [Value in pulmonary diseases of a new broad spectrum semi-synthetic penicillin: amoxicillin]. Poumon Coeur. 1973;29(4):473-8.
Middleton FG, Poretz DM, Duma RJ. Clinical and laboratory evaluation of amoxicillin (BRL 2333) in the treatment of urinary tract infections. Antimicrob Agents Chemother. 1973 Jul;4(1):25-30.
Neder AC, Gama Mde L, Ranali J, Arbex ST, Arruda JV, Renci J, Garlipp OF, Neder NR. Amoxicilina (Wintramox) em odontologia [Amoxicillin (wintramox) in dentistry]. Quintessencia. 1978 Nov;5(11):75-81.
Shanson DC, Cannon P, Wilks M. Amoxycillin compared with penicillin V for the prophylaxis of dental bacteraemia. J Antimicrob Chemother. 1978 Sep;4(5):431-6.
Angelini F, Levy G, Roux C. Expérimentation clinique d'un antibiotique dans le cadre de l'odontologie conservatrice [Clinical experimentation with an antibiotic in conservative dentistry]. Inf Dent. 1979 Apr 26;61(17):1431-9.
Re G, Chicco R. Primi risultati clinici sull'impiego in odontostomatologia e in chirurgia maxillo-facciale di un nuovo antibiotico: lo Zimox [Initial clinical results from the use of a new antibiotic, Zimox, in dentistry and maxillofacial surgery]. Minerva Stomatol. 1979 Oct-Dec;28(4):355-8.
Pankey GA. The use of antibiotics in dentistry. Compend Contin Educ Gen Dent. 1980 Sep-Oct;1(5):324-6, 330-1.
Lewis MA, Lamey PJ, Gibson J. Quantitative bacteriology of a case of acute parotitis. Oral Surg Oral Med Oral Pathol. 1989 Nov;68(5):571-5.
Goené RJ, Winkel EG, Abbas F, Rodenburg JP, van Winkelhoff AJ, de Graaff J. Microbiology in diagnosis and treatment of severe periodontitis. A report of four cases. J Periodontol. 1990 Jan;61(1):61-4.
Magnusson I, Clark WB, Low SB, Maruniak J, Marks RG, Walker CB. Effect of non-surgical periodontal therapy combined with adjunctive antibiotics in subjects with "refractory" periodontal disease. (I). Clinical results. J Clin Periodontol. 1989 Nov;16(10):647-53.
Iwu C, MacFarlane TW, MacKenzie D, Stenhouse D. The microbiology of periapical granulomas. Oral Surg Oral Med Oral Pathol. 1990 Apr;69(4):502-5.
Lewis MA, MacFarlane TW, McGowan DA. Antibiotic susceptibilities of bacteria isolated from acute dentoalveolar abscesses. J Antimicrob Chemother. 1989 Jan;23(1):69-77.
Ahmadi H, Ebrahimi A, Ahmadi F. Antibiotic Therapy in Dentistry. Int J Dent. 2021;2021:6667624
AbdelRahman R, Al Rikaby O, Abu-Hammad O, Dar-Odeh N. Knowledge and attitudes towards antibiotic prescribing among dentists in Sudan. Pesqui. Bras. Odontopediatria Clínica Integr.2019;19: e4430.
Jovanović M, Milosavljević M, Zdravković D, Živić M, Veličković S, Janković S. Septic arthritis of the temporomandibular joint in adults: Systematic review. J Stomatol Oral Maxillofac Surg. 2022;123(4):465-472.
Levorova J, Machon V, Guha A, Foltan R. Septic arthritis of the temporomandibular joint caused by rare bacteria Raoultella ornithinolytica. Int J Oral Maxillofac Surg. 2017;46(1):111-115.
Digital Medicines Information Suite | MedicinesComplete. https://about.medicinescomplete.com/#/content/martindale/18258-v (accessed Aug. 03, 2022).
Guillemot D, Carbon C, Balkau B, Geslin P, Lecoeur H, Vauzelle-Kervroëdan F, Bouvenot G, Eschwége E. Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA. 1998 Feb 4;279(5):365-70.
de Velde F, de Winter BC, Koch BC, van Gelder T, Mouton JW; COMBACTE-NET consortium. Non-linear absorption pharmacokinetics of amoxicillin: consequences for dosing regimens and clinical breakpoints. J Antimicrob Chemother. 2016 Oct;71(10):2909-17.
Copyright (c) 2022 Najla Dar-Odeh, Osama Abu-Hammad, Ismail Abdouh, Rawah Eshky, Nebras althagafi, Safa Jambi, Shaden Abu-Hammad
This work is licensed under a Creative Commons Attribution 4.0 International License.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access and Benefits of Publishing Open Access).
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Articles are published Under License of Creative Commons Attribution 3.0 License Â©
Copyright policies & self-archiving
This is our Copyright Policy. We are a RoMEO green journal.
|Author's Pre-print:||author can archive pre-print (ie pre-refereeing)|
|Author's Post-print:||author can archive post-print (ie final draft post-refereeing)|
|Publisher's Version/PDF:||author can archive publisher's version/PDF|